Corrigendum: Interleukin-13 as a potential biomarker in the management of pediatric asthma – a longitudinal study

Prasanna Raju
ID
Email src
Subash Sundar
ID
Preethi Suresh
ID
Leela Kakithakara Vajravelu
ID
Vivekanandhan Aravindhan
ID
Department of Paediatrics, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur Campus, Chennai, Tamilnadu, India
Department of Paediatrics, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur Campus, Chennai, Tamilnadu, India
Department of Paediatrics, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur Campus, Chennai, Tamilnadu, India
Department of Microbiology, SRM Medical College Hospital and Research Centre, SRM Institute of Science and Technology, Kattankulathur Campus, Chennai, Tamilnadu, India
Department of Genetics, University of Madras, Chennai, India

Abstract

A Corrigendum on

Interleukin-13 as a potential biomarker in the management of pediatric asthma – a longitudinal study by Raju P, Sundar S, Suresh P, Vajravelu LK, Aravindhan V. Eur J Clin Exp Med. 2025;23(1):15–20. doi: 10.15584/ ejcem.2025.1.3.

 

Cite

Raju P, Sundar S, Suresh P, Vajravelu LK, Aravindhan V. Corrigendum: Interleukin-13 as a potential biomarker in the management of pediatric asthma – a longitudinal study. Eur J Clin Exp Med. 2025;23(2):531. doi: 10.15584/ejcem.2025.2.29.

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited